WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi
2269.HKCommitted to net-zero across the value chain by 2050 Aligned with 1.5°C mitigation pathways, the most ambitious SBTi designation Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, Aug. 28, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract...
August 28, 2025ESG
Read more →